Keep up to date with the latest news and articles from BMC Urology and BioMed Central.
Research article
miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer
Sabrina T Reis*, José Pontes-Junior, Alberto A Antunes, Marcos F Dall’Oglio, Nelson Dip, Carlo C Passerotti, Guilherme A Rossini, Denis R Morais, Adriano J Nesrallah, Camila Piantino, Miguel Srougi and Katia R Leite